The Effectiveness of Intravitreal Avastin Injection for CRVO

NCT ID: NCT01678248

Last Updated: 2012-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

68 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to determine the effectivness of intravitreal avastin injection on visual acuity on people that suffer from central retinal vein occlusion

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Retinal Vein Occlusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients above 18 years old
* suffer from CRVO
* maximal visual acuity 6/15

Exclusion Criteria

* VA of LP
* retinal disease other than CRVO
* incomplete medical record
* follow up less than 6 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ziv Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ziv Medical Center

Safed, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Joseph pikkel, M.D

Role: CONTACT

Phone: 972508434206

Email: [email protected]

Otzem Chassid, M.D

Role: CONTACT

Phone: 972506266059

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Otzem Chassid, M.D

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0048-12-ZIV

Identifier Type: -

Identifier Source: org_study_id